Jump to start of content

ABIM Scheduled Maintenance Expand/Collapse the ABIM alert.

ABIM.org will be going through scheduled maintenance from 6 p.m. ET to 10 p.m. ET on Sat., 6/15/24. During this time, the ABIM Physician Portal will be unavailable. We apologize for any inconvenience this may cause. Thank you for your patience.

Breadcrumb trail:

Pulmonary Disease Approval Committees

Longitudinal Knowledge Assessment

Expand All | Collapse All

Neil S. Freedman, MD, Chair

Neil S. Freedman, MDDr. Freedman is the Division Head of Pulmonary, Critical Care, Allergy and Immunology at the Northshore University Health System in Evanston, Illinois. He holds the academic rank of Clinical Associate Professor of Medicine at the University of Chicago Pritzker School of Medicine and he is board certified in Pulmonary Disease, Critical Care Medicine and Sleep Medicine. At Northshore, he spends approximately 80% of his time in direct patient care activities with the remainder of his time dedicated to administrative responsibilities. In addition to his clinical and administrative roles, he serves on the Board of Trustees of The Northshore Medical Group Faculty Practice Associates and is Vice President of the Professional Staff.

Previously, Dr. Freedman was in private practice for 12 years as a partner in Pulmonary Physicians of the Northshore in Bannockburn, Illinois.

Dr. Freedman is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. He has volunteered for several professional societies in leadership and educational roles. He currently serves as a member of the American College of Chest Physicians (ACCP) Chest Foundation Board of Trustees, has recently chaired the ACCP sleep network and previously served on the ACCP joint finance oversight and education committees. He has been a member of the ACCP and Associated Professional Sleep Societies scientific program committees and was the chair of the scientific program committee for CHEST Annual meeting in 2016.

As an educator and clinician, Dr. Freedman has delivered more than 250 presentations at national and international meetings on the topics of sleep, pulmonary and critical care medicine. He has chaired post-graduate courses and general sessions at national meetings for several professional societies and recently was the chair of the ACCP Sleep Medicine Board Review Course from 2013 to 2016. His educational efforts have been recognized with the Excellence in Education Award from the American Academy of Sleep Medicine in 2016 and the ACCP Distinguished Chest Educator in 2017.

Dr. Freedman received a biology degree from Washington and Jefferson College in Washington, Pennsylvania, and his medical degree at the Mount Sinai School of Medicine in New York. He completed his internship and residency in internal medicine and fellowships in pulmonary, critical care and sleep medicine at the Hospital of the University of Pennsylvania.

As of May 2023, Dr. Freedman reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • UpToDate®, receiving compensation for authorship

Dr. Freedman serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The American College of Chest Physicians, Health Policy and Advocacy Committee, Member; Finance Committee, Chair; Board of Regents, Member, receiving reimbursement for travel expenses

Nitin Bhatt, MD

Dr. Bhatt is a pulmonary/critical care and sleep medicine physician at The Ohio State University. Dr. Bhatt has a strong clinical and academic interest in interstitial lung diseases. He has been Medical Director of the Interstitial Lung Diseases Center and led its participation in the Pulmonary Fibrosis Foundation (PFF) Care Center Network and Patient Registry. Within this organization, he is also a member of the Exposure Working Group and co-Chair of the Benchmarking Committees. He has also been involved with the American Thoracic Society Environmental Health Policy Committee and the American College of Chest Physicians Occupational & Environmental Health NetWork Steering Committee.

His background includes basic science research in monocyte and macrophage biology as related to interstitial lung diseases, and have been involved in therapeutic clinical trials, including studies in interstitial lung disease and idiopathic pulmonary fibrosis, and associated conditions including autoimmune disease and pulmonary hypertension. He has a clinical interest in pulmonary physiology and pulmonary function testing and has been Medical Director of Ohio State's Pulmonary Diagnostics and Bronchoscopy Labs. He is board certified and actively practicing sleep medicine.

He earned a bachelor's degree in electrical engineering from Ohio State and completed his internal medicine training and pulmonary/critical care fellowship training also at Ohio State University.

As of May 2022, Dr. Bhatt reported no ongoing external relationships.

Jacqueline Chang, MD

Dr. Chang is a pulmonary critical care physician in practice at Scripps Clinic in La Jolla, California since 1999. She is board certified in Internal Medicine, Critical Care, and Pulmonary Medicine, and currently the Division Head of Pulmonary, Critical Care, and Sleep Medicine at Scripps Clinic, a position she has held since 2006. She has also the Medical Director for all the pulmonary function laboratories at Scripps Clinic and Medical Director of the Thoracic Oncology Service. In addition, she is an affiliate appointment with MD Anderson through the partnership between Scripps and MD Anderson. She has also served important leadership roles in Scripps Clinic Medical Group including the Medical Executive Committee and the leadership selection committees.

Her current responsibilities are primarily clinical practice with a particular emphasis on fibrosing parenchymal lung disease, along with commitment to her administrative duties, including teaching of internal medicine residents, and some clinical research.

Dr. Chang received her undergraduate degree in biology and economics with honors in both through Stanford University. She received her medical degree and internal medicine residency training through Stanford University. She completed her subspecialty training in pulmonary and critical care medicine at the University of Washington, where she also obtained a masters in epidemiology through their School of Public health.

As of May 2023, Dr. Chang reported the following external relationship:

Dr. Chang is employed by Scripps Clinic Medical Group.

Karen A. Fagan, MD

Karen A. Fagan, MDDr. Fagan is Chief, Division of Pulmonary and Critical Care Medicine at the University of South Alabama (USA) in Mobile, where she is also Professor of Medicine and Pharmacology. She is a member of the Center for Lung Biology and Director of the Pulmonary Hypertension Center at USA Health. Prior to this role, Dr. Fagan was a faculty member in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado, eventually rising to Associate Professor. At Colorado, she developed a clinical and scientific interest in pulmonary hypertension and received a National Institute of Health K08 award followed by R01s and other extramural and intramural funding. In addition, she has served on numerous committees and leadership positions in the Pulmonary Hypertension Association and the American Thoracic Society.

Dr. Fagan has maintained certification in Internal Medicine, Pulmonary Medicine and Critical Care Medicine continuously since 1995 and strongly supports the mission of the American Board of Internal Medicine to improve healthcare by certifying providers with the necessary knowledge to provide excellent care to their patients and the community.

Dr. Fagan graduated with her bachelor’s and medical degrees from the University of California San Diego and completed internship and residency in internal medicine at the University of Texas Southwestern Medical School in Dallas, Texas. After residency, she completed fellowship training in pulmonary and critical care medicine at the University of Colorado in Denver.

As of May 2023, Dr. Fagan reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • UpToDate®, receiving annual royalties for an online educational resource for lymphocytic interstitial pneumonia

Dr. Fagan serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • The American Thoracic Society, Representative to the Council of Subspecialty Societies of the American College of Physicians, receiving reimbursement for travel expenses

Dr. Fagan also reported that she receives honoraria for serving on data and safety monitoring boards for the National Institutes of Health for clinical trials on pulmonary arterial hypertension.

Jerry Krishnan, MD

Dr. Krishnan is Professor of Medicine, Professor of Public Health, and Associate Vice Chancellor for Population Health Sciences at the University of Illinois(UI) Chicago. He is responsible for developing, testing, and implementing healthcare interventions to improve care, outcomes, and affordability of care for populations served by UI Health System.

Dr. Krishnan is a leader in the field of healthcare delivery science, including the development of clinical guidelines, clinical effectiveness ("real-world") research, implementation science, and integration of human-centered design in healthcare. He is a member of research consortia funded by National Institute of Health, Patient Centered Outcomes Research Institute, and the American Lung Association for studies in asthma, chronic obstructive pulmonary disease (COPD), and COVID-19.

He participates in several national and international advisory groups or committees. Examples include National Heart, Lung, and Blood Institute (NHLBI)NIH CONNECTS Steering Committee, European Respiratory Society / American Thoracic Society COPD Exacerbations Guidelines (past Chair), FDA Pulmonary and Allergy Drugs Advisory Committee (past chair), NIH/NHLBI Clinical Trials Review Committee (past chair), NIH/National Center for Advancing Translational Sciences Special Emphasis Panel for Clinical and Translational Sciences Awards (ad hoc member), NIH/NHLBI EPR-4 Working Group (member), and Global Initiative for Asthma. He is an Associate Editor for the American Journal of Respiratory and Critical Care Medicine.

He received his medical degree with honors from Baylor College of Medicine in Houston, Texas, and completed a residency in internal medicine and fellowship in pulmonary/critical care medicine at the Johns Hopkins Hospital, Baltimore, Maryland.  He received his doctoral degree in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.

As of June 2023, Dr. Krishnan reported the following external relationships:

Service on a research-related expert panel or advisory board for the following companies, with honoraria:

  • AstraZeneca, for asthma medications
  • BData, for severe asthma registry
  • CereVu, for a device regarding dyspnea

Dr. Krishnan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The COPD Foundation, Medical Scientific Advisory Board, without compensation
  • The Global Initiative for Asthma, receiving reimbursement for travel expenses
  • The Respiratory Health Association, Board of Directors, without compensation

Serge Nana-Sinkam, MD

As of August 2022, Dr. Nana-Sinkam reported no ongoing external relationships.

Traditional, 10-Year MOC Exam

Expand All | Collapse All

Anne Dixon, MD, MA, BM BCh, Chair

Dr. Dixon is Director of Pulmonary and Critical Care Medicine at the University of Vermont Larner College of Medicine. She is board certified in Pulmonary Disease and Critical Care Medicine.

Since 2001, Dr. Dixon has been an attending physician in the pulmonary and critical care division at the University of Vermont Medical Center. She has served on numerous committees for this organization, including serving as a member of the Board of Trustees of the University of Vermont Medical Group. In addition, she also leads an active research program in obesity and lung disease at the University of Vermont.

Dr. Dixon is a member of the American Board of Internal Medicine Pulmonary Disease Board Exam Committee. She has served on numerous national committees and review boards for the American Thoracic Society, the American Lung Association-Airways Clinical Research Centers, the National Institutes of Health and the Veteran’s Administration.

She received a degree in natural sciences from the University of Cambridge and her medical degree from Oxford University both in England. Dr. Dixon completed residency training at the Johns Hopkins Hospital, Baltimore, Maryland and fellowship training at the University of Washington in Seattle.

As of May 2023, Dr. Dixon reported no ongoing external relationship.

Rita Bakhru, MD

Dr. Bakhru is an Associate Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the Medical University of South Carolina (MUSC). She is Board Certified in Pulmonary Disease and Critical Care Medicine. She previously served on the faculty at Wake Forest University School of Medicine.

Dr. Bakhru spends her clinical time in the ICU and running an ICU Recovery Clinic. She is the Associate Program Director for the Critical Care Fellowship at MUSC and Director of the Specialty Medical ICU.

Dr. Bakhru completed her training in internal medicine at the University of Michigan and a fellowship in Pulmonary/Critical Care Medicine at the University of Pennsylvania, as well as a master’s degree in clinical epidemiology.

As of September 2023, Dr. Bakhru reported the following external relationship:

Grant funding from the following nonprofit healthcare-related organization:

  • Duke University, endowment for salary support, staff and expenses.

Nishant Gupta, MD, MS

Nishant Gupta MD, MSDr. Gupta is ABIM Board Certified in Internal Medicine, Pulmonary Disease and Critical Care Medicine, and is participating in Maintenance of Certification.

Dr. Gupta completed his medical training at the University of Delhi, India, followed by internal medicine residency at the University of Tennessee and fellowships in pulmonary and critical care medicine at the University of Cincinnati. In addition, he has completed fellowship training in the field of rare lung diseases, as well as a master’s degree in clinical and translational research at the University of Cincinnati.

As of May 2023, Dr. Gupta reported the following external relationships:

Funding for clinical trial expenses, staff and salary support, paid to the University of Cincinnati, from the following companies:

  • aTyR Pharma, Site Principal Investigator, receiving funding for salary support and project expenses
  • Bellerophon Therapeutics, Site Principal Investigator, receiving funding for salary support and project expenses
  • Boehringer Ingelheim, Site Principal Investigator, receiving funding for salary support and project expenses
  • Celgene, Site Principal Investigator, receiving funding for salary support and project expenses
  • CSL Behring, Site Principal Investigator, receiving funding for salary support and project expenses
  • Fibrogen, Site Principal Investigator, receiving funding for salary support and project expenses
  • Galapagos, Site Principal Investigator, receiving funding for salary support and project expenses
  • Galecto Bioetech, Site Principal Investigator, receiving funding for salary support and project expenses
  • United Therapeutics, Site Principal Investigator, receiving funding for salary support and project expenses

Service on data and safety monitoring boards for the following company, with honoraria:

  • LabCorp

Work as an author or editor for the following companies, with compensation as listed:

  • Springer, receiving compensation as editor for a textbook on diffuse cystic lung diseases
  • Thieme, receiving compensation as editor-in-chief for Seminars in Respiratory and Critical Care Medicine
  • UpToDate®, receiving compensation for authorship

Dr. Gupta serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The LAM Foundation, Scientific Advisory Board, Member and Scientific Director, without compensation
  • Tuberous Sclerosis Alliance, Tuberous Sclerosis Complex Bio-Sample Repository and Natural History Database Project, Steering Committee, Member, without compensation
  • Sjögren's Foundation, Board of Directors, Member, without compensation

Dr. Gupta also reported receiving funding for clinical trial salary support from the National Institutes of Health, paid to the University of Cincinnati, for the following trials:

  • Co-Principal Investigator for R01HL143011-01A1 (IPF MRI)
  • Co-Principal Investigator for R01HL126771 (IPF MRI Duke)
  • Co-Principal Investigator for U01HL131755-01 (MILED)
  • Principal Investigator for CHEST Foundation grant for global dissemination of the LAM Guidelines
  • Principal Investigator for R13HL165802
  • Principal Investigator for R21TR003858

Susheel Patil, MD, PhD

Dr. Patil is the System Director and Section Chief for Sleep Medicine at the University Hospitals of Cleveland and a Clinical Associate Professor of Medicine at Case Western Reserve University. He is board certified in Pulmonary, Critical Care and Sleep Medicine.

Dr. Patil was previously the clinical director of The Johns Hopkins Sleep Medicine program and the Fellowship Director of the Johns Hopkins Sleep Medicine Fellowship program in Baltimore, Maryland. He has been active in national and regional leadership with roles with the American Thoracic Society, CHEST, and American Academy of Sleep Medicine. He was formerly part of the exam writing committee for the American Board of Internal Medicine Sleep Medicine examination. He is the former President of the Maryland Sleep Society. He has authored more than 30 publications. Dr. Patil has longstanding research interesting in the pathogenesis of obstructive sleep apnea and clinical trials in sleep apnea therapeutics.

He completed his training in pulmonary, critical care, and sleep medicine at Johns Hopkins University and his doctoral degree in clinical investigation at the Bloomberg School of Public Health at Johns Hopkins.

As of September 2022, Dr. Patil reported the following external relationships:

Work as an author or editor for the following company, with compensation as listed:

  • The American College of Chest Physicians, CHEST, Associate Editor, receiving compensation

Dr. Patil serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The American Academy of Sleep Medicine, Committee Member of Inpatient Sleep Medicine Clinical Practice Guidelines Taskforce, without compensation
  • The American Thoracic Society, Advocacy Committee Chair for Sleep and Respiratory Neurobiology, without compensation

Maria Patricia Rivera, MD

Dr. Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina (UNC) at Chapel Hill. She is Board certified in Internal Medicine and Pulmonary Diseases. She specializes in lung cancer screening, diagnosis, staging, and management of treatment complications and currently serves as co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening (LCS) Program at UNC.

She is the currently Chair of the Thoracic Oncology Network of the American College of Chest Physicians (ACCP) and immediate past Chair of the Thoracic Oncology Assembly of the ATS. She has led ATS research workshops on the impact of co-morbidities on LCS, disparities in LCS, and immunotherapy induced lung disease. She serves as Vice Chair of the Lung Cancer in Women Task Force and of the Biomarker Task Force of the National Lung Cancer Round Table (NLCRT), charged to promote awareness of lung cancer as a women's health imperative and barriers to biomarker testing.

Her research interests include lung cancer in women and lung cancer screening. Dr. Rivera is an active participant in the ACCP Lung Cancer Guidelines Initiative and have had an integral part in the guideline's development. She is currently an investigator in National Institutes of Health funded grants to examine the delivery, quality and outcomes of lung cancer screening in North Carolina, and co-Principal Investigator of a study to explore rural/urban disparities associated with biomarker testing. Throughout her career, she has worked effectively in multidisciplinary clinical and research settings, using my expertise in lung cancer to promote evidence-based screening, diagnosis, staging and treatment.

As of August 2021, Dr. Rivera reported the following external relationships:

Funding for clinical trials, including research staff and expenses, paid to the University of North Carolina at Chapel Hill, from the following company:

  • Biodesix Technologies, for a biomarker study.
  • BioAffinitym for a biomarker study.

Dr. Rivera serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American Thoracic Society, Chair, Vice President, without compensation.
  • American College of Chest Physicians, Chair, Thoracic Oncology Network, without compensation.
  • American Cancer Society, National Lung Cancer Round Table Member, Vice-Chair, Lung Cancer in Women Task Force; Member, Triage for Appropriate Treatment Task Force, without compensation.

Grant funding for salary support, paid to the University of North Carolina-Chapel Hill, from nonprofit healthcare-related organization:

  • National Cancer Institute, for an R01 Grant.

Jennifer Svetlecic, MD

Dr. Svetlecic is Board Certified in Pulmonary Disease and Critical Care Medicine. Since 2005, Dr. Svetlecic has been an attending physician in the St. Luke’s Health System in Kansas City, where she sees patients in the hospital and clinic, and virtually via telemedicine. She was elected by her peers to three terms as Chair of the Department of Medicine at St. Luke's North Hospital and served as its Director of Respiratory Medicine. For the St. Luke's Health System, Dr. Svetlecic was the Director of Medical Staff Development and Chair of the Professional Standards and Credentialing Committee.

Dr. Svetlecic most recently served as a member of the ABIM Item-Writing Task Force for Pulmonary Disease. She also currently serves as an outside expert peer reviewer on complex cases through Chartis (formerly The Greeley Company). Dr. Svetlecic formerly held an appointment at the University of Missouri, Kansas City (UMKC) School of Medicine as an Associate Clinical Professor of Medicine and served as a guest faculty member in the Cardiopulmonary Section at the Kansas City University of Medicine and Biosciences.

Dr. Svetlecic received her undergraduate degree in biology and medical degree from UMKC. She also completed a residency in internal medicine and fellowships in pulmonary disease and critical care medicine at the UMKC.

As of July 2023, Dr. Svetlecic reported no ongoing external relationships.

Corey Ventetuolo, MD

Dr. Ventetuolo is an Associate Professor of Medicine and Health Services, Policy, and Practice at Brown University and Director of Academic Affairs for the Pulmonary, Critical Care and Sleep Division at Brown. She is the Associate Director of the Rhode Island Hospital Pulmonary Hypertension Center and Medical Director of the Adult Extracorporeal Life Support Program.

Her work focuses on sexual dimorphism in pulmonary arterial hypertension (PAH) and right ventricular function, hormonal modulation as a treatment strategy, and novel methods of endotyping patients with pulmonary vascular disease. She is also interested in improving quality of care for patients with pulmonary hypertension and those on extracorporeal life support. Dr. Ventetuolo is supported by the American Heart Association and the National Institutes of Health.

Dr. Ventetuolo completed her medical degree at Tufts University School of Medicine in Boston, Massachusetts, her residency at Rhode Island Hospital in Providence and her fellowship at New York Presbyterian Hospital.

As of June 2023, Dr. Ventetuolo reported the following external relationships:

Service on a research-related advisory board for the following company, with honoraria:

  • Johnson & Johnson

Consulting on the design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following companies, with compensation for travel expenses and/or honoraria:

  • Enzyment, receiving reimbursement for travel expenses and honoraria
  • Merck, receiving honoraria
  • Regeneron, receiving honoraria

Work as an author or editor for the following company, with compensation as listed:

  • The American Thoracic Society, Associate Editor, Annals of the American Thoracic Society

Dr. Ventetuolo serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The Pulmonary Hypertension Association, Communications Committee; Scientific Leadership Committee, without compensation
  • The American Thoracic Society, Pulmonary Circulation Program Committee, Chair, receiving reimbursement for travel expenses